AMPH
Price
$23.45
Change
-$1.13 (-4.60%)
Updated
Jun 25 closing price
Capitalization
2.11B
46 days until earnings call
PAHC
Price
$24.75
Change
-$0.02 (-0.08%)
Updated
Jun 25 closing price
Capitalization
523.71M
62 days until earnings call
Interact to see
Advertisement

AMPH vs PAHC

Header iconAMPH vs PAHC Comparison
Open Charts AMPH vs PAHCBanner chart's image
Amphastar Pharmaceuticals
Price$23.45
Change-$1.13 (-4.60%)
Volume$426.89K
Capitalization2.11B
Phibro Animal Health
Price$24.75
Change-$0.02 (-0.08%)
Volume$282.6K
Capitalization523.71M
AMPH vs PAHC Comparison Chart in %
Loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMPH vs. PAHC commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPH is a StrongBuy and PAHC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (AMPH: $23.45 vs. PAHC: $24.75)
Brand notoriety: AMPH and PAHC are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMPH: 85% vs. PAHC: 123%
Market capitalization -- AMPH: $2.11B vs. PAHC: $523.71M
AMPH [@Pharmaceuticals: Other] is valued at $2.11B. PAHC’s [@Pharmaceuticals: Other] market capitalization is $523.71M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMPH’s FA Score shows that 0 FA rating(s) are green whilePAHC’s FA Score has 1 green FA rating(s).

  • AMPH’s FA Score: 0 green, 5 red.
  • PAHC’s FA Score: 1 green, 4 red.
According to our system of comparison, PAHC is a better buy in the long-term than AMPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMPH’s TA Score shows that 6 TA indicator(s) are bullish while PAHC’s TA Score has 3 bullish TA indicator(s).

  • AMPH’s TA Score: 6 bullish, 4 bearish.
  • PAHC’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, AMPH is a better buy in the short-term than PAHC.

Price Growth

AMPH (@Pharmaceuticals: Other) experienced а -7.46% price change this week, while PAHC (@Pharmaceuticals: Other) price change was +3.30% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.94%. For the same industry, the average monthly price growth was +13.35%, and the average quarterly price growth was +95.35%.

Reported Earning Dates

AMPH is expected to report earnings on Aug 11, 2025.

PAHC is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.94% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMPH($2.11B) has a higher market cap than PAHC($524M). PAHC has higher P/E ratio than AMPH: PAHC (34.11) vs AMPH (16.69). PAHC YTD gains are higher at: 19.035 vs. AMPH (-36.844). AMPH has higher annual earnings (EBITDA): 240M vs. PAHC (83.7M). AMPH has more cash in the bank: 257M vs. PAHC (92.5M). PAHC has less debt than AMPH: PAHC (513M) vs AMPH (624M). PAHC has higher revenues than AMPH: PAHC (982M) vs AMPH (644M).
AMPHPAHCAMPH / PAHC
Capitalization2.11B524M403%
EBITDA240M83.7M287%
Gain YTD-36.84419.035-194%
P/E Ratio16.6934.1149%
Revenue644M982M66%
Total Cash257M92.5M278%
Total Debt624M513M122%
FUNDAMENTALS RATINGS
AMPH vs PAHC: Fundamental Ratings
AMPH
PAHC
OUTLOOK RATING
1..100
7116
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
24
Undervalued
PROFIT vs RISK RATING
1..100
8787
SMR RATING
1..100
4562
PRICE GROWTH RATING
1..100
6442
P/E GROWTH RATING
1..100
9091
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PAHC's Valuation (24) in the Pharmaceuticals Major industry is somewhat better than the same rating for AMPH (63) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew somewhat faster than AMPH’s over the last 12 months.

PAHC's Profit vs Risk Rating (87) in the Pharmaceuticals Major industry is in the same range as AMPH (87) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew similarly to AMPH’s over the last 12 months.

AMPH's SMR Rating (45) in the Pharmaceuticals Other industry is in the same range as PAHC (62) in the Pharmaceuticals Major industry. This means that AMPH’s stock grew similarly to PAHC’s over the last 12 months.

PAHC's Price Growth Rating (42) in the Pharmaceuticals Major industry is in the same range as AMPH (64) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew similarly to AMPH’s over the last 12 months.

AMPH's P/E Growth Rating (90) in the Pharmaceuticals Other industry is in the same range as PAHC (91) in the Pharmaceuticals Major industry. This means that AMPH’s stock grew similarly to PAHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMPHPAHC
RSI
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
63%
Bearish Trend 1 day ago
72%
Momentum
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 1 day ago
69%
MACD
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
70%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 1 day ago
69%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
68%
Bullish Trend 1 day ago
72%
Advances
ODDS (%)
Bullish Trend 17 days ago
72%
Bullish Trend 3 days ago
69%
Declines
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 7 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
58%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JLGPX80.81N/A
N/A
JPMorgan Large Cap Growth R3
CCALX73.52N/A
N/A
Conestoga Small Cap Institutional
LMCTX32.74N/A
N/A
Lord Abbett Mid Cap Stock R5
AMAHX9.85N/A
N/A
American Century Small Cap Dividend A
RRESX30.01-0.51
-1.67%
Russell Inv Global Real Estate Secs S

AMPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMPH has been loosely correlated with AMRX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if AMPH jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMPH
1D Price
Change %
AMPH100%
-4.60%
AMRX - AMPH
39%
Loosely correlated
-0.98%
COLL - AMPH
38%
Loosely correlated
-1.06%
PAHC - AMPH
33%
Poorly correlated
-0.08%
HROW - AMPH
32%
Poorly correlated
-0.50%
ALKS - AMPH
32%
Poorly correlated
-1.53%
More

PAHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, PAHC has been loosely correlated with PBH. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PAHC jumps, then PBH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAHC
1D Price
Change %
PAHC100%
-0.08%
PBH - PAHC
51%
Loosely correlated
-3.46%
AMRX - PAHC
44%
Loosely correlated
-0.98%
ZTS - PAHC
42%
Loosely correlated
-0.34%
VTRS - PAHC
39%
Loosely correlated
-0.67%
ELAN - PAHC
35%
Loosely correlated
+1.85%
More